These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 23881705)

  • 1. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.
    Zhao W; Beers DR; Appel SH
    J Neuroimmune Pharmacol; 2013 Sep; 8(4):888-99. PubMed ID: 23881705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.
    Beers DR; Henkel JS; Zhao W; Wang J; Huang A; Wen S; Liao B; Appel SH
    Brain; 2011 May; 134(Pt 5):1293-314. PubMed ID: 21596768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective.
    Malaspina A; Puentes F; Amor S
    Int Immunol; 2015 Mar; 27(3):117-29. PubMed ID: 25344935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity in amyotrophic lateral sclerosis.
    Moisse K; Strong MJ
    Biochim Biophys Acta; 2006; 1762(11-12):1083-93. PubMed ID: 16624536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis.
    Thonhoff JR; Simpson EP; Appel SH
    Curr Opin Neurol; 2018 Oct; 31(5):635-639. PubMed ID: 30048339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.
    Hooten KG; Beers DR; Zhao W; Appel SH
    Neurotherapeutics; 2015 Apr; 12(2):364-75. PubMed ID: 25567201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an early innate immune response in the motor cortex of ALS.
    Jara JH; Genç B; Stanford MJ; Pytel P; Roos RP; Weintraub S; Mesulam MM; Bigio EH; Miller RJ; Özdinler PH
    J Neuroinflammation; 2017 Jun; 14(1):129. PubMed ID: 28651542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A system mathematical model of a cell-cell communication network in amyotrophic lateral sclerosis.
    Shao H; He Y; Li KC; Zhou X
    Mol Biosyst; 2013 Mar; 9(3):398-406. PubMed ID: 23287963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.
    Rizzo F; Riboldi G; Salani S; Nizzardo M; Simone C; Corti S; Hedlund E
    Cell Mol Life Sci; 2014 Mar; 71(6):999-1015. PubMed ID: 24100629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation.
    Sta M; Sylva-Steenland RM; Casula M; de Jong JM; Troost D; Aronica E; Baas F
    Neurobiol Dis; 2011 Jun; 42(3):211-20. PubMed ID: 21220013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice.
    Beers DR; Zhao W; Liao B; Kano O; Wang J; Huang A; Appel SH; Henkel JS
    Brain Behav Immun; 2011 Jul; 25(5):1025-35. PubMed ID: 21176785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune adaptor TRIF deficiency accelerates disease progression of ALS mice with accumulation of aberrantly activated astrocytes.
    Komine O; Yamashita H; Fujimori-Tonou N; Koike M; Jin S; Moriwaki Y; Endo F; Watanabe S; Uematsu S; Akira S; Uchiyama Y; Takahashi R; Misawa H; Yamanaka K
    Cell Death Differ; 2018 Dec; 25(12):2130-2146. PubMed ID: 29568058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes.
    Gorter RP; Stephenson J; Nutma E; Anink J; de Jonge JC; Baron W; Jahreiβ MC; Belien JAM; van Noort JM; Mijnsbergen C; Aronica E; Amor S
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):459-475. PubMed ID: 30346063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
    Evans MC; Couch Y; Sibson N; Turner MR
    Mol Cell Neurosci; 2013 Mar; 53():34-41. PubMed ID: 23110760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Role of the Major Histocompatibility Complex Class I in Amyotrophic Lateral Sclerosis.
    Chiarotto GB; Nardo G; Trolese MC; França MC; Bendotti C; Rodrigues de Oliveira AL
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?
    Appel SH; Beers DR; Henkel JS
    Trends Immunol; 2010 Jan; 31(1):7-17. PubMed ID: 19879804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications.
    Calma AD; Pavey N; Menon P; Vucic S
    Curr Opin Neurol; 2024 Oct; 37(5):585-592. PubMed ID: 38775138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Haukedal H; Freude K
    J Mol Biol; 2019 Apr; 431(9):1818-1829. PubMed ID: 30763568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor neuron-immune interactions: the vicious circle of ALS.
    Barbeito AG; Mesci P; Boillée S
    J Neural Transm (Vienna); 2010 Aug; 117(8):981-1000. PubMed ID: 20552235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.